Through the outcomes of current positive clinical trials, specifically Rick Dobson’s work on MDMA at MAPS (Multidisciplinary Association for Psychedelic Studies), the efficacy and safely of psychedelic medicines within a clinical setting, namely LSD, Psilocybin, MDMA and Ketamine have been proven highly beneficial to people suffering from specific mental illnesses.
Currently, I am in training to become a Ketamine Assisted Psychotherapist (KAP). At present, KAP is the only legal psychedelic treatment for trauma, PTSD, depression, suicidality, treatment resistant depression and addictions.
I work closely with a Cape Town based KAP clinic. They administer the medicine and manage the journey whilst I do the Preparation and Integration Psychotherapy work, following the universal standardized KAP protocols.